Takahashi T - Search Results

1

Genetic alterations of multiple tumor suppressors and oncogenes in the carcinogenesis and progression of lung cancer.

Osada H, Takahashi T. Osada H, et al. Among authors: takahashi t. Oncogene. 2002 Oct 21;21(48):7421-34. doi: 10.1038/sj.onc.1205802. Oncogene. 2002. PMID: 12379883 Review.

2

Identification of frequent G(2) checkpoint impairment and a homozygous deletion of 14-3-3epsilon at 17p13.3 in small cell lung cancers.

Konishi H, Nakagawa T, Harano T, Mizuno K, Saito H, Masuda A, Matsuda H, Osada H, Takahashi T. Konishi H, et al. Among authors: takahashi t. Cancer Res. 2002 Jan 1;62(1):271-6. Cancer Res. 2002. PMID: 11782387

3

Aberrant hypermethylation of the CHFR prophase checkpoint gene in human lung cancers.

Mizuno K, Osada H, Konishi H, Tatematsu Y, Yatabe Y, Mitsudomi T, Fujii Y, Takahashi T. Mizuno K, et al. Among authors: takahashi t. Oncogene. 2002 Apr 4;21(15):2328-33. doi: 10.1038/sj.onc.1205402. Oncogene. 2002. PMID: 11948416

4

Frequent and histological type-specific inactivation of 14-3-3sigma in human lung cancers.

Osada H, Tatematsu Y, Yatabe Y, Nakagawa T, Konishi H, Harano T, Tezel E, Takada M, Takahashi T. Osada H, et al. Among authors: takahashi t. Oncogene. 2002 Apr 4;21(15):2418-24. doi: 10.1038/sj.onc.1205303. Oncogene. 2002. PMID: 11948426

5

Significant up-regulation of a novel gene, CLCP1, in a highly metastatic lung cancer subline as well as in lung cancers in vivo.

Koshikawa K, Osada H, Kozaki K, Konishi H, Masuda A, Tatematsu Y, Mitsudomi T, Nakao A, Takahashi T. Koshikawa K, et al. Among authors: takahashi t. Oncogene. 2002 Apr 25;21(18):2822-8. doi: 10.1038/sj.onc.1205405. Oncogene. 2002. PMID: 11973641

6

Lung cancer: an ever increasing store of in-depth basic knowledge and the beginning of its clinical application.

Takahashi T. Takahashi T. Oncogene. 2002 Oct 7;21(45):6868-9. doi: 10.1038/sj.onc.1205830. Oncogene. 2002. PMID: 12362268 Review. No abstract available.

7

Chromosome instability in human lung cancers: possible underlying mechanisms and potential consequences in the pathogenesis.

Masuda A, Takahashi T. Masuda A, et al. Among authors: takahashi t. Oncogene. 2002 Oct 7;21(45):6884-97. doi: 10.1038/sj.onc.1205566. Oncogene. 2002. PMID: 12362271 Review.

8

Decreased expression of 14-3-3sigma in neuroendocrine tumors is independent of origin and malignant potential.

Yatabe Y, Osada H, Tatematsu Y, Mitsudomi T, Takahashi T. Yatabe Y, et al. Among authors: takahashi t. Oncogene. 2002 Nov 28;21(54):8310-9. doi: 10.1038/sj.onc.1206014. Oncogene. 2002. PMID: 12447694

9

Detailed characterization of a homozygously deleted region corresponding to a candidate tumor suppressor locus at distal 17p13.3 in human lung cancer.

Konishi H, Sugiyama M, Mizuno K, Saito H, Yatabe Y, Takahashi T, Osada H, Takahashi T. Konishi H, et al. Among authors: takahashi t. Oncogene. 2003 Mar 27;22(12):1892-905. doi: 10.1038/sj.onc.1206304. Oncogene. 2003. PMID: 12660825

10

RASSF1A gene inactivation in non-small cell lung cancer and its clinical implication.

Endoh H, Yatabe Y, Shimizu S, Tajima K, Kuwano H, Takahashi T, Mitsudomi T. Endoh H, et al. Among authors: takahashi t. Int J Cancer. 2003 Aug 10;106(1):45-51. doi: 10.1002/ijc.11184. Int J Cancer. 2003. PMID: 12794755

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14,997 results

Search Page

Filters